Tevogen Inc. (TVGN)
NASDAQ: TVGN · Real-Time Price · USD
6.78
-0.28 (-3.97%)
At close: Oct 9, 2026, 4:00 PM EDT
7.09
+0.31 (4.57%)
After-hours: Oct 9, 2026, 7:58 PM EDT
Tevogen Market Cap
Tevogen has a market cap or net worth of $106.69 million as of October 9, 2026. It is the 24,992nd most valuable company in the world and the 4,071st biggest in the United States. Its market cap has decreased by 25.07% in one year.
Market Cap
106.69M
Enterprise Value
115.05M
1-Year Change
-25.07%
Global Rank
Country Rank
#4,071 United States
Category
ChartMarket Cap Chart
Since January 5, 2022, Tevogen's market cap has decreased from $446.69M to $106.69M, a decrease of -76.11%. That is a compound annual growth rate of -25.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 106.69M | 62.18% |
| Dec 31, 2025 | 65.79M | -63.51% |
| Dec 31, 2024 | 180.30M | 2.42% |
| Dec 29, 2023 | 176.04M | -64.45% |
| Dec 30, 2022 | 495.15M | 10.85% |
| Jan 5, 2022 | 446.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Foghorn Therapeutics | 118.18M |
| Coya Therapeutics | 117.05M |
| Unicycive Therapeutics | 113.37M |
| Inovio Pharmaceuticals | 112.70M |
| PMV Pharmaceuticals | 112.51M |
| Genelux | 112.03M |
| Vivani Medical | 110.95M |
| LENZ Therapeutics | 110.91M |